Fig. 7.

Ang-1* decreases the expression of inflammatory molecules in the intestine of mice treated with rAd-FGF-2 + PPS. A: representative Western blots in samples derived from the small intestine of mice treated with rAd-FGF-2 + PPS or rAd-FGF-2 + rAd-Ang1* + PPS (60 mg/kg). B: the densitometric analysis corresponding to the Western blots. Results are expressed in arbitrary optical density units as a ratio of the beta-actin expression (means ± SE). Samples from the small intestine of 6 different mice were included in each group (*P < 0.05, **P < 0.001 compared with mice treated with rAd-FGF-2 + PPS).